Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025

Q1 FY23 results · Apr–Jun 2022

Advanced Enzyme Technologies reported revenue from operations of ₹121.12 crore (down 11.6% from Q1 FY22) and net profit of ₹17.58 crore (down 55.9% from Q1 FY22) for Q1 FY23 (Apr–Jun 2022), on a consolidated basis.

Consolidated · ₹ crore
ItemQ1 FY23Q1 FY22YoYQ4 FY22QoQ
Revenue from operations121.12137.01−11.6%131.73−8.1%
Other income1.990.93+113.7%3.38−41.0%
Total income123.12137.95−10.8%135.12−8.9%
Profit before tax23.7054.93−56.9%33.95−30.2%
Net profit for the period17.5839.86−55.9%25.25−30.4%
Attributable to shareholders of the company17.8738.04−53.0%24.43−26.8%
EPS, basic (₹)1.603.40−52.9%2.19−26.9%
Net margin (%)14.529.119.2
Standalone · ₹ crore
ItemQ1 FY23Q1 FY22YoYQ4 FY22QoQ
Revenue from operations72.1172.75−0.9%70.75+1.9%
Other income1.250.94+32.0%5.17−75.9%
Total income73.3673.69−0.5%75.92−3.4%
Profit before tax10.2825.09−59.0%17.97−42.8%
Net profit for the period7.7818.55−58.1%14.35−45.8%
EPS, basic (₹)0.701.66−57.8%1.28−45.3%
Net margin (%)10.825.520.3
Consolidated
Filed with BSE
08 Aug 2022, 17:08 IST
Board meeting
06 Aug 2022
Period
01 Apr 2022 to 30 Jun 2022
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
08 Aug 2022, 17:08 IST
Board meeting
06 Aug 2022
Period
01 Apr 2022 to 30 Jun 2022
Review status
Unaudited
Source
XBRL filing on BSE